SHARE THIS PAGE:
University of Virginia News, Sam Caneda (04.10.24) reported, “She Aided the Team Taking the Bite Out of Tick-Borne Lyme Disease.” Toriana “Tori” Vigil, a University of Virginia (UVA) chemical engineering Ph.D. student was the advisor to US Air Force Academy students who won a gold medal for the idea of the “Lyme-AID” biosensor patch at the International Genetically Engineered Machine (IGEM) competition in Paris in 2023.
360 Dx published announcement 01.25.2024, that the diagnostic laboratory research company, DiaSorin, has submitted a new test for the early identification of Lyme disease, for approval by US Food and Drug Administration (FDA).The Liaison LymeDetect test, an immunoassay, was developed in partnership with Qiagen.
An article regarding recent study on effectiveness of permethrin-treated uniforms against ticks was conducted at Department of Defense (DOD) Military Tick Identification/Infection Confirmation Kit Program (MilTICK program) was published by […]
Emerging Infectious Diseases (McCormick, D.W., et al.) 3.23, has published a Medscape Continuing Medical Education (CME) Activity; “Bartonella spp. Infections Identified by Molecular Methods, United States.” The authors describe how […]
Arick P.Sabin, et al., published “Clinical evaluation of a Borrelia modified two-tiered testing (MTTT) shows increased early sensitivity for Borrelia burgdorferi but not other endemic Borrelia species in a high incidence region for Lyme disease in Wisconsin” in Diagnostic Microbiology and Infectious Disease on November 9, 2022,* (version of record). Recently, a modified two-tiered testing algorithm (MTTT; ZEUS Scientific) for Borrelia burgdorferi was cleared by the FDA. This led the researchers to assess the algorithm to verify Lyme disease as well as evaluate the results in comparison to those acquired using standard two-tiered testing (STTT).
Daniel J.B. Clarke, et al, published “Gene set predictor for post-treatment Lyme disease” in Cell Reports Medicine on November 15, 2022. The researchers enrolled 152 study participants, each with symptoms of post-treatment Lyme disease (PTLD), to analyze their peripheral blood mononuclear cells (PBMCs) with RNA sequencing (RNA-seq). RNA-seq data from 72 individuals with acute Lyme disease and 44 uninfected controls were incorporated to examine variations in differential gene expression.
Venice Servellita, et al., published results of a study in Communications Medicine designed to address the urgent need for new diagnostic tests with improved sensitivity and specificity for Lyme disease.
New study shows that detection of Borrelia prophages, equated as “footprints” of Borrelia, can be used to identify the bacteria due to the close correlation between them and the exact prophages found in each Borrelia host.
As part of the LymeX public-private partnership between Health & Human Services (HHS) and the Cohen Foundation, HHS has published an RFI in the Federal Register, 2.11.21 that seeks information […]
Elizabeth Maloney, MD, explains current Lyme disease testing issues, including the ELISA and Western Blot, sensitivity and specificity of the testing, and the problems associated with the two-tier testing recommended […]
LDA Doctor Referral System © Terms & Conditions and Guidelines
Save this Information for Your Records:
About LDA DOCTOR REFERRAL SYSTEM ©
Welcome to the Lyme Disease Association’s LDA Doctor Referral System ©. LDA made updates and enhancements to its prior system and has launched a new site to provide patients with information about doctors, other practitioners, testing labs, and pharmacies that are knowledgeable about chronic Lyme disease and often about many other tick-borne diseases (TBD). Many of the doctors listed are often referred to as Lyme Literate Physicians/Doctors (LLMD). Tens of thousands of patients have successfully used the prior LDA system to locate Lyme and TBD resources.
Terms & Conditions and Guidelines
Because there is a negative political climate surrounding Lyme disease, many LLMDs do not want their names posted outright on the internet. LDA has tried to balance the doctors’ wishes with patients’ need to find a doctor. This new system is a result of that compromise and therefore:
Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines, Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the LDA Doctor Referral System © contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the location entered and specaialty/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of so we can investigate.